CyDex Pharmaceuticals Overview
- Year Founded
-
1993

- Status
-
Acquired/Merged
- Employees
-
11

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$35.5M
CyDex Pharmaceuticals General Information
Description
Developer of drug delivery technology based in San Diego, California. The company utilizes four Captisol-enabled products commercialized by Pfizer and Bristol-Myers Squibb (BMS) to address asthma, depression, allergy, cancer and arrhythmia disease states.
Contact Information
Website
www.captisol.com(Operating Subsidiary)
Corporate Office
- 3911 Sorrento Valley Road
- Suite 110
- San Diego, CA 92121
- United States
Corporate Office
- 3911 Sorrento Valley Road
- Suite 110
- San Diego, CA 92121
- United States
CyDex Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 26-Jan-2011 | $35.5M | Completed | Clinical Trials - Phase 2 | ||
4. Later Stage VC | 24-Mar-2010 | Completed | Generating Revenue | |||
3. IPO | 28-Oct-2008 | Cancelled | Clinical Trials - Phase 2 | |||
2. Early Stage VC (Series B) | 17-Aug-2004 | $17M | $29M | Completed | Clinical Trials - Phase 2 | |
1. Early Stage VC (Series A) | 11-Oct-2000 | $12M | $12M | Completed | Clinical Trials - Phase 2 |
CyDex Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A1 | ||||||||
Series A | 16,464,622 | $0.010000 | 7% | $0.73 | $0.73 | 1x | $0.73 | 15.99% |
CyDex Pharmaceuticals Comparisons
Industry
Financing
Details
CyDex Pharmaceuticals Competitors (6)
One of CyDex Pharmaceuticals’s 6 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
Bluebird Bio | Formerly VC-backed | Somerville, MA | ||||
Celldex Therapeutics | Formerly VC-backed | Hampton, NJ | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan |
CyDex Pharmaceuticals Patents
CyDex Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4217404-A1 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Pending | 24-Sep-2020 | ||
US-20230357451-A1 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Pending | 24-Sep-2020 | ||
EP-4217404-A4 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Pending | 24-Sep-2020 | ||
US-20230002513-A1 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Pending | 18-Nov-2019 | ||
CA-3161566-A1 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Pending | 18-Nov-2019 | C08B37/0012 |
CyDex Pharmaceuticals Signals
CyDex Pharmaceuticals Former Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Clariden Investment | Venture Capital | Minority | ||
Eastman Ventures | Corporate Venture Capital | Minority | ||
Edelman Financial Engines | PE-Backed Company | Minority | ||
Private Equity Direct Finance | PE/Buyout | Minority | ||
RiverVest Venture Partners | Venture Capital | Minority |
CyDex Pharmaceuticals FAQs
-
When was CyDex Pharmaceuticals founded?
CyDex Pharmaceuticals was founded in 1993.
-
Where is CyDex Pharmaceuticals headquartered?
CyDex Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of CyDex Pharmaceuticals?
CyDex Pharmaceuticals has 11 total employees.
-
What industry is CyDex Pharmaceuticals in?
CyDex Pharmaceuticals’s primary industry is Drug Delivery.
-
Is CyDex Pharmaceuticals a private or public company?
CyDex Pharmaceuticals is a Private company.
-
What is the current valuation of CyDex Pharmaceuticals?
The current valuation of CyDex Pharmaceuticals is
. -
What is CyDex Pharmaceuticals’s current revenue?
The current revenue for CyDex Pharmaceuticals is
. -
How much funding has CyDex Pharmaceuticals raised over time?
CyDex Pharmaceuticals has raised $29M.
-
Who are CyDex Pharmaceuticals’s investors?
Clariden Investment, Eastman Ventures, Edelman Financial Engines, Private Equity Direct Finance, and RiverVest Venture Partners are 5 of 9 investors who have invested in CyDex Pharmaceuticals.
-
Who are CyDex Pharmaceuticals’s competitors?
Sutro Biopharma, Inovio Pharmaceuticals, Bluebird Bio, Celldex Therapeutics, and Pfizer Pakistan are some of the 6 competitors of CyDex Pharmaceuticals.
-
When was CyDex Pharmaceuticals acquired?
CyDex Pharmaceuticals was acquired on 26-Jan-2011.
-
Who acquired CyDex Pharmaceuticals?
CyDex Pharmaceuticals was acquired by Ligand Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »